论文信息 - Can 24‐h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?

Can 24‐h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?

1. Locarnini S, Omata M. Molecular virology of hepatitis B virus and the development of antiviral drug resistance. Liver Int 2006; 26: 11–22. 2. Van Bommel F, Wunsche T, Mauss S, et al. Comparison of adefovir and tenofovir in the treatment of lamivudine resistant hepatitis B virus infection. Hepatology 2004; 40: 1421–5. 3. Chang TT, Gish RG, Hadziyannis SJ, et al. A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine refractory chronic hepatitis B patients. Gastroenterology 2005; 129: 1198–209. 4. Yim HJ, Hussain M, Liu Y, et al. Evolution of multidrug resistant hepatitis B virus during sequential therapy. Hepatology 2006; 44: 703–12. 5. Sherman M, Yurdaydin C, Simsek H, et al. Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks. Hepatology 2008; 48: 99–108. 6. Sherman M, Yurdaydin C, Sollano J, et al. Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B. Gastroenterology 2006; 130: 2039–49. 7. Tenney DJ, Rose RE, Baldick CJ, et al. Longterm monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology 2009; 49: 1503–14. 8. Qi X, Xiong S, Yang H, et al. In vitro susceptibility of adefovir associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther 2007; 12: 355–62.

[1] I. Shin,et al. [Diagnostic usefulness of the random urine Na/K ratio in cirrhotic patients with ascites: a pilot study]. , 2010, The Korean journal of hepatology.

[2] H. Shalaby,et al. Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites. , 2009, World journal of gastroenterology.

[3] B. Runyon. Management of adult patients with ascites due to cirrhosis: An update , 2009, Hepatology.

[4] M. Omata,et al. Molecular virology of hepatitis B virus and the development of antiviral drug resistance , 2006 .

[5] Y. Liu,et al. Evolution of multi‐drug resistant hepatitis B virus during sequential therapy , 2006, Hepatology.

[6] E. Schiff,et al. A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients. , 2005, Gastroenterology.

[7] T. Berg,et al. Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection , 2004, Hepatology.

[8] B. Runyon,et al. Detection of diuretic-resistance or diuretic-sensitivity by the spot urine Na+/K+ ratio in 729 specimens from cirrhotics with ascites Approximately 90% accuracy as compared to 24-hour urine Na+ excretion , 2002 .